Table 2 Demographic data of study groups and maternal risk factors
From: Evaluation of inhaled beta-2 agonist in management of transient tachypnea of the newborn
Variables | Group I (saline) | Group II (salbutamol) | P value |
|---|---|---|---|
Number | 46 | 54 | |
Sex (M/F) | 27/19 | 32/22 | 0.995 |
Gestational age (weeks ± SD) | 36.85 ± 1.57 | 36.73 ± 1.66 | 0.504 |
Birth weight (gm ± SD) | 2883.15 ± 437.94 | 2825.87 ± 414.61 | 0.731 |
Hemoglobin (g/dl) | 15.33 ± 1.49 | 15.12 ± 1.55 | 0.481 |
Weight blood cell count (/mm3) | 16,283 ± 3141 | 16,591 ± 1884 | 0.446 |
Elective cesarean section/NVD | 27/19 | 31/23 | 0.897 |
Apgar score (5th min)* | 9 | 9 | 0.27 |
Oxygen saturation (%) | 88.7 ± 3.98 | 89.96 ± 3.93 | 0.15 |
Duration of respiratory support (h) | 61.43 ± 16.81 | 49.17 ± 15.86 | 0.0005 |
Duration of hospitalization (days) | 4.76 ± 1.14 | 3.89 ± 1.08 | 0.0002 |
Maternal risk factors | |||
Maternal age | 29.12 ± 4.45 | 28.53 ± 4.78 | 0.499 |
Maternal diabetes | 3 | 5 | |
PROM | 3 | 2 | |